AI for Pheochromocytoma and Paraganglioma Risk Stratification

AI for Pheochromocytoma and Paraganglioma Risk Stratification

"Using Artificial Intelligence for Risk Stratification in Pheochromocytomas and Paragangliomas"

We are pleased to share the results of a research collaboration between the Department of Pathology at Ankara University Faculty of Medicine and the Simplex Artificial Intelligence Team, which also formed the core of a specialty thesis at Ankara University.

The research explores the potential of artificial intelligence to support the prediction of metastatic risk in pheochromocytomas and paragangliomas—an important challenge in determining patient prognosis and planning appropriate follow-up strategies.

As part of the project, histopathological findings evaluated according to the GAPP (Grading system for adrenal phaeochromocytoma and paraganglioma) framework were combined with artificial intelligence methods to investigate whether computational models can contribute to more effective risk stratification.

For Simplex, this collaboration represents more than an individual research project. We believe that meaningful innovation in medical AI requires close collaboration between clinicians, researchers and technology teams. We therefore continue to invest our engineering expertise and AI resources in academic research, particularly in pathology and medical imaging, with the aim of transforming scientific ideas into technologies that can ultimately contribute to clinical practice.

#SimplexIT #SimplexResearch #ArtificialIntelligence #MedicalAI #Pathology #DigitalPathology #Pheochromocytoma #Paraganglioma #GAPP #HealthcareInnovation

← All news